Novagevity (Sperri), a Halifax, Nova Scotia-based plant-based nutrition company, has secured CAD$344,602 in non-dilutive, non-repayable funding from Natural Products Canada (NPC) through its Proof of Concept program.
Announced on October 22, 2026, the contribution will support a CAD$861,507 project focused on validating and optimizing two products under Novagevity’s Sperri brand. NPC’s contribution represents approximately 40% of the total project budget.
Founded in 2019 by entrepreneur Gregg Curwin and physician Dr. Mary Lynch, Novagevity develops plant-based nutritional products designed to provide complete meal replacement options. Its Sperri brand offers organic beverages formulated without dairy, gluten, soy or artificial ingredients.
The company was established after Lynch identified challenges among patients who required nutritional support but had difficulty tolerating conventional meal replacement products. Novagevity subsequently developed Sperri with input from physicians, dietitians and food scientists.
The NPC-backed project covers two products:
- Sperri Control: A nutritional beverage targeting glycemic health.
- Sperri Kids: A pediatric oral nutrition supplement designed for children’s nutritional needs.
According to NPC, the formulations are intended to deliver higher protein and fibre content with reduced sugar while remaining free from gluten, soy, dairy and artificial ingredients. The funding will support further product validation and optimization.
Natural Products Canada’s Proof of Concept program supports Canadian companies developing natural products and technologies by financing activities that demonstrate commercial feasibility. Its funding is structured as a non-dilutive, non-repayable contribution rather than an equity investment.
Novagevity previously received a CAD$250,000 venture capital investment from Invest Nova Scotia, disclosed in September 2025, to support the distribution and sales growth of its Sperri products.
The latest contribution forms part of NPC’s October 2026 announcement of CAD$1,016,330 in funding for five Canadian early-stage companies, supporting a combined CAD$2,543,328 in project activities across three provinces.
